Literature DB >> 1370807

Single-strand conformation polymorphism (SSCP) analysis of exon 11 of the CFTR gene reliably detects more than one third of non-delta F508 mutations in German cystic fibrosis patients.

J Plieth1, F Rininsland, M Schlösser, D N Cooper, J Reiss.   

Abstract

In Central Europe, the delta F508 deletion accounts for approximately 75% of mutations in the cystic fibrosis transmembrane conductance regulator gene causing cystic fibrosis. The remainder comprise a large number of individually infrequent mutations whose detection requires a disproportionately large effort. However, a sizeable proportion of non-delta F508 mutations have been found to cluster within exon 11. We have taken advantage of this clustering to detect a total of five previously described point mutations present on 26/72 (36%) non-delta F508 chromosomes by polymerase chain reaction/direct sequencing of exon 11. These exon 11 mutations were then subjected to single-strand conformation polymorphism (SSCP) analysis, which was shown (i) to discriminate reliably between mutant and wildtype alleles and (ii) to generate reproducible mutation-specific band patterns. This analysis thus represents the first attempt to assess SSCP analysis retrospectively, and serves to illustrate the potential of this screening technique in diagnostic medicine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370807     DOI: 10.1007/bf00197260

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

3.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.

Authors:  O Attree; D Vidaud; M Vidaud; S Amselem; J M Lavergne; M Goossens
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

5.  Detection of single base substitutions in total genomic DNA.

Authors:  R M Myers; N Lumelsky; L S Lerman; T Maniatis
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

6.  Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

Authors:  M Vidaud; P Fanen; J Martin; N Ghanem; S Nicolas; M Goossens
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Benign missense variations in the cystic fibrosis gene.

Authors:  K Kobayashi; M R Knowles; R C Boucher; W E O'Brien; A L Beaudet
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

View more
  8 in total

1.  Two cystic fibrosis patients with the genotype G542X/G551D.

Authors:  J Reiss; U Ellermeyer; M Schloesser; W Fuhrmann; D Drews; H G Posselt
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

2.  Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene.

Authors:  U Lenk; R Hanke; U Kräft; K Grade; I Grunewald; A Speer
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

3.  Identification of a new DMD gene deletion by ectopic transcript analysis.

Authors:  F Rininsland; A Hahn; S Niemann-Seyde; R Slomski; F Hanefeld; J Reiss
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

4.  A novel CFTR mutation, 4035delA, detected by non-radioactive SSCP analysis.

Authors:  J Reiss; U Lenz; F Rininsland; P Ballhausen; D Drews; H G Posselt
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

5.  Molecular genetic analysis of 67 patients with Duchenne/Becker muscular dystrophy.

Authors:  S Niemann-Seyde; R Slomski; F Rininsland; U Ellermeyer; J Kwiatkowska; J Reiss
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

6.  The spectrum of CFTR mutations in south-west German cystic fibrosis patients.

Authors:  M Lindner; A Wolf; B Moh; P Steinbach; E Kleihauer; C R Bartram; A E Kulozik
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

7.  Common CFTR mutations are not likely to predispose to chronic bronchitis in northern Germany.

Authors:  A Artlich; A Boysen; S Bunge; P Entzian; M Schlaak; E Schwinger
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

8.  Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.

Authors:  C R Pullinger; L K Hennessy; J E Chatterton; W Liu; J A Love; C M Mendel; P H Frost; M J Malloy; V N Schumaker; J P Kane
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.